Live-cell imaging, integrated with AI/ML, enhances phenotypic screening, improving drug discovery and lead optimization. European companies are pioneering live-cell imaging technologies, advancing in ...
Abstract: Complex research (histological, detection of LYVE-1 by immunohistochemical method, 3D-modeling of an image of LYVE-1 expression by the Nanolive microscope) of the skin of patients with ...
Background: Cellular imaging analysis using the traditional retrospective approach is extremely time-consuming and labor-intensive. Although AI-based solutions are available, these approaches rely ...
Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Medical Holography Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The medical holography market is ...
Introduction: Cytomegalovirus (CMV) infection reorganizes early endosomes (EE), recycling endosome (RE), and trans-Golgi network (TGN) and expands their intermediates into a large perinuclear ...
Tomocube is experiencing a sharp decline compared to its IPO price on the first day of listing on the KOSDAQ market. As of 10:29 AM on the 7th, Tomocube is trading at 11,700 KRW, down 26.88% from its ...
No articles found. Nanolive SA did not contribute to any primary research papers from Nature Index journals in the current 12 month window. Identify research insights to guide research strategy and ...
How did cells evolve a process to end their own lives? Recent research suggests that apoptosis, a form of programmed cell death, first arose billions of years ago in bacteria with a primitive ...
The positions in the table below reflect the Nanolive SA's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...
Within our Centre for Systems Health and Integrated Metabolic Research (SHiMR), the foundation of innovation is embodied by our state-of-the-art Imaging and Technology Facilities. This impressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback